LF
ATRS

Lee Financial’s Antares Pharma, Inc. ATRS Stock Holding History

Lee Financial’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-50
Closed – – 846
2018
Q1 		$0 Buy
+50
New +$113 ﹤0.01% 785

Other funds holding ATRS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MWP
MYCIO Wealth Partners Philadelphia, Pennsylvania $502M AUM 11.65% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lee Financial's ATRS Position: Q2 2018 in Review

Lee Financial sold out of Antares Pharma, Inc. (ATRS) in Q2 2018, closing a stake of 50 shares.

Lee Financial first reported a position in ATRS in Q1 2018 and held it in 1 quarter. The position peaked at $0 in Q1 2018. 101 funds tracked by Wall St. Rank hold ATRS as of Q2 2018.

  • Lee Financial reported no remaining Antares Pharma, Inc. position as of Q2 2018 after selling out during the quarter.
  • Lee Financial sold 50 Antares Pharma, Inc. shares in Q2 2018.
  • Lee Financial first reported a position in Antares Pharma, Inc. in Q1 2018 and held it in 1 quarter.
  • Lee Financial's Antares Pharma, Inc. position peaked at $0 in Q1 2018.
  • 101 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2018.

Based on Lee Financial's 13F filing for Q2 2018, filed 14 Aug 2018.